Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
DAB389IL-2 suppresses autoimmune inflammation in the CNS and inhibits T cell-mediated lysis of glial target cells.
Attention-Deficit/Hyperactivity Disorder in Offspring of Mothers With Inflammatory and Immune System Diseases.
Use of a biomarker in exposure-response analysis to support dose selection for fingolimod.
Longitudinal associations between brain structural changes and fatigue in early MS.
Assessment of microRNA-related SNP effects in the 3' untranslated region of the IL22RA2 risk locus in multiple sclerosis.
"I knew what was going to happen if I did nothing and so I was going to do something": Faith, hope, and trust in the decisions of Canadians with multiple sclerosis to seek unproven interventions abroad.
Cross-validation of oxygen uptake prediction during walking in ambulatory persons with multiple sclerosis.
Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.
Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy.
Neurological involvement in primary sjögren syndrome: a focus on central nervous system.
[The metabolic abnormalities in plaques of multiple sclerosis patients - the assessment in proton MR spectroscopy (1HMRS)].
A reliability study of colour-Doppler sonography for the diagnosis of chronic cerebrospinal venous insufficiency shows low inter-rater agreement.
White matter disease: Longest follow-up of rituximab for neuromyelitis optica.
Brain networks disconnection in early multiple sclerosis cognitive deficits: An anatomofunctional study.
Door-to-door survey of major neurological disorders (project) in Al Quseir City, Red Sea Governorate, Egypt.
B cells in MS and NMO: pathogenesis and therapy.
Natural history of multiple sclerosis from the Indian perspective: Experience from a tertiary care hospital.
Neuromyelitis optica spectrum disorders.
[Oculomotor system and multiple sclerosis.]
Neuropsychiatric Lupus: The Prevalence and Autoantibody Associations Depend on the Definition: Results from the 1000 Faces of Lupus Cohort.
Onset and outcome of pregnancy after autologous haematopoietic SCT (AHSCT) for autoimmune diseases: a retrospective study of the EBMT autoimmune diseases working party (ADWP).
Degenerative Cervical Myelopathy: A Spectrum of Related Disorders Affecting the Aging Spine.
Interleukin-17A Levels Vary in Relapsing-Remitting Multiple Sclerosis Patients in Association with Their Age, Treatment and the Time of Evolution of the Disease.
Microenvironmental Regulation of Oligodendrocyte Replacement and Remyelination in Spinal Cord Injury.
Multiple sclerosis: getting personal with induced pluripotent stem cells.
Pages
« first
‹ previous
…
499
500
501
502
503
504
505
506
507
…
next ›
last »